Nektar Therapeutics NKTR
NASDAQ · United States · Health Technology
$46.99-13.56 (-22.39%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -1.23 | -1.97 | +37.6% | $10.13M | -2.8% | -4.0%$76.03→$73.02 |
| Q1 2026 | 2026-05-07 | -1.78 | -1.48 | -20.3% | — | — | -3.8%$85.09→$81.89 |
| Q4 2025 | 2026-03-12 | -1.29 | -3.49 | +63.0% | — | — | -0.1%$73.33→$73.25 |
| Q3 2025 | 2025-11-06 | -1.87 | -2.79 | +33.0% | — | — | +3.2%$54.26→$55.97 |
| Q2 2025 | 2025-08-07 | -2.78 | -3.12 | +10.9% | — | — | — |
| Q1 2025 | 2025-05-08 | -3.61 | -2.82 | -28.0% | — | — | — |
| Q4 2024 | 2025-03-12 | -2.25 | -2.92 | +22.9% | — | — | — |
| Q3 2024 | 2024-11-07 | -2.65 | -3.09 | +14.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.